<DOC>
	<DOCNO>NCT01779466</DOCNO>
	<brief_summary>This trial investigate relationship sleep , daytime performance nocturia patient treat Desmopressin placebo . Male Female patient administer Desmopressin Placebo every day 3 month .</brief_summary>
	<brief_title>Daytime Impact Sleep Study</brief_title>
	<detailed_description />
	<mesh_term>Nocturia</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<criteria>At least 2 night time void per night Habitual sleep 69.5 hour per night Experiencing symptom Nocturia great 6 month Greater 10 night time void History sleep apnoea PLMS ( Periodic Limb Movements Sleep ) Other sleep disorder Signs symptom : Bladder outlet obstruction , severe low urinary tract symptom ( LUTS ) , interstitial cystitis , moderate severe overactive bladder ( OAB ) , moderate severe judge investigator stress urinary incontinence Urological malignancy Neurogenic detrusor activity ( e.g . Parkinson , spinal cord damage , etc . ) Central nephrogenic diabetes insipidus Habitual psychogenic polydipsia ( fluid intake result urine production exceed 40ml/Kg/24hrs ) Syndrome inappropriate antidiuretic hormone ( SIADH ) Cardiac failure evidence base physical examination , cardiac medical history electrocardiogram ( ECG ) output Uncontrolled hypertension Uncontrolled diabetes mellitus Hyponatraemia sodium &lt; 135 mmol/L Renal insufficiency Known suspect clinically significant hepatic and/or biliary disease</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>